HUMANA INC (HUM) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31..
Borrowing debt
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 12.27B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities |
| Total assets | 55.28B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | (m) | (m) | $12.27B | (m) | (m) | $55.28B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $12.37B | (m) | (m) | $48.91B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $12.61B | (m) | (m) | $49.72B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $12.59B | (m) | (m) | $50.36B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $12.73B | (m) | (m) | $50.93B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $11.14B | (m) | (m) | $46.48B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $11.89B | (m) | (m) | $50.01B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $11.75B | (m) | (m) | $50.09B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $12.39B | (m) | (m) | $50.09B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $10.21B | (m) | (m) | $47.06B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $9.48B | (m) | (m) | $55.91B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $9.72B | (m) | (m) | $56.45B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $9.74B | (m) | (m) | $54.78B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $9.03B | (m) | (m) | $43.05B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $7.80B | (m) | (m) | $50.77B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $11.29B | (m) | (m) | $46.82B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $11.29B | (m) | (m) | $46.31B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $10.54B | (m) | (m) | $44.36B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $11.47B | (m) | (m) | $45.32B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $6.06B | (m) | (m) | $38.07B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $6.06B | (m) | (m) | $37.41B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $6.06B | (m) | (m) | $34.97B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $6.06B | (m) | (m) | $38.48B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $6.06B | (m) | $20.00B | $38.45B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $6.06B | (m) | $17.16B | $34.63B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $4.97B | (m) | $15.03B | $29.07B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $5.37B | (m) | $15.96B | $29.18B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $4.38B | (m) | $14.77B | $28.91B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $4.38B | (m) | $13.75B | $28.35B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $4.38B | (m) | $12.37B | $25.41B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $4.77B | (m) | $13.84B | $27.49B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $4.77B | (m) | $17.52B | $34.27B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $4.77B | (m) | $18.60B | $33.45B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $4.77B | (m) | $13.60B | $27.18B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $3.98B | (m) | $18.49B | $32.96B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $4.28B | (m) | $16.25B | $32.25B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $4.78B | (m) | $16.63B | $31.71B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $3.79B | (m) | $11.47B | $25.40B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $3.79B | (m) | $14.10B | $29.47B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $3.79B | (m) | $9.85B | $27.24B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $3.79B | (m) | $10.54B | $26.93B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $3.82B | (m) | $9.84B | $24.70B | (m) |
| 2015-09-30 | (m) | (m) | (m) | $3.82B | (m) | $9.02B | $24.30B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $3.82B | (m) | $9.29B | $25.38B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $3.82B | (m) | $9.55B | $25.62B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $3.83B | (m) | $9.53B | $23.47B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $3.83B | (m) | $10.79B | $24.33B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $2.60B | (m) | $9.16B | $23.12B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $2.60B | (m) | $9.91B | $22.57B | (m) |
| 2013-12-31 | (m) | (m) | (m) | $2.60B | (m) | $9.23B | $20.73B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $2.60B | (m) | $9.52B | $20.90B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $2.61B | (m) | $9.07B | $20.85B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $2.61B | (m) | $9.54B | $20.97B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $2.61B | (m) | $9.31B | $19.98B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $1.62B | (m) | $9.42B | $18.80B | (m) |
| 2012-06-30 | (m) | (m) | (m) | $1.62B | (m) | $11.75B | $20.86B | (m) |
| 2012-03-31 | (m) | (m) | (m) | $1.62B | (m) | $11.54B | $20.70B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $1.66B | (m) | $9.12B | $17.71B | (m) |
| 2011-09-30 | (m) | (m) | (m) | $1.66B | (m) | $11.88B | $19.90B | (m) |
| 2011-06-30 | (m) | (m) | (m) | $1.66B | (m) | $9.18B | $17.59B | (m) |
| 2011-03-31 | (m) | (m) | (m) | $1.67B | (m) | $9.18B | $17.16B | (m) |
| 2010-12-31 | (m) | (m) | (m) | $1.67B | (m) | $8.55B | $16.10B | (m) |
| 2010-09-30 | (m) | (m) | (m) | $1.67B | (m) | $10.07B | $16.39B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $1.67B | (m) | $8.88B | $15.69B | (m) |
| 2010-03-31 | (m) | (m) | (m) | $1.68B | (m) | $8.58B | $15.21B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $1.68B | (m) | $7.80B | $14.15B | (m) |
| 2009-09-30 | (m) | (m) | (m) | $1.68B | (m) | $7.35B | $14.20B | (m) |
| 2009-06-30 | (m) | (m) | (m) | $1.68B | (m) | $6.17B | $13.68B | (m) |
| 2008-12-31 | (m) | (m) | (m) | $1.94B | (m) | $6.17B | $13.04B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |